The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
Tóm tắt
Từ khóa
Tài liệu tham khảo
McDonald, 2000, Relapse, remission, and progression in multiple sclerosis, N. Engl. J. Med., 343, 1486, 10.1056/NEJM200011163432010
Hickey, 1999, The pathology of multiple sclerosis: a historical perspective, J. Neuroimmunol., 98, 37, 10.1016/S0165-5728(99)00079-X
Rudick, 1999, Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group, J. Neuroimmunol., 93, 8, 10.1016/S0165-5728(98)00174-X
Weiner, 2002, Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects, Mult. Scler., 8, 142, 10.1191/1352458502ms790oa
Calabresi, 2002, Considerations in the treatment of relapsing-remitting multiple sclerosis, Neurology, 58, S10, 10.1212/WNL.58.8_suppl_4.S10
Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502
Bitsch, 2000, Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation, Brain, 123, 1174, 10.1093/brain/123.6.1174
Kappos, 1999, Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group, Lancet, 353, 964, 10.1016/S0140-6736(98)03053-0
Trebst, 2001, CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis, Am. J. Pathol., 159, 1701, 10.1016/S0002-9440(10)63017-9
Ransohoff, 1997, Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology, J. Leukoc. Biol., 62, 645, 10.1002/jlb.62.5.645
Bennetts, 1997, The CCR5 deletion mutation fails to protect against multiple sclerosis, Hum. Immunol., 58, 52, 10.1016/S0198-8859(97)00207-3
Barcellos, 2000, CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group, Immunogenetics, 51, 281, 10.1007/s002510050621
Sellebjerg, 2000, CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis, J. Neuroimmunol., 102, 98, 10.1016/S0165-5728(99)00166-6
The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of genomic screens in multiple sclerosis. Mult Scler 2001;7:3–11.
Sawcer, 1996, A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22, Nat. Genet., 13, 464, 10.1038/ng0896-464
Thorpe, 1996, Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis, Neurology, 46, 373, 10.1212/WNL.46.2.373
Zlotnik, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X
Fife, 2000, CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis, J. Exp. Med., 192, 899, 10.1084/jem.192.6.899
Huang, 2001, Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis, J. Exp. Med., 193, 713, 10.1084/jem.193.6.713
Matsushima, 1988, Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor, J. Exp. Med., 167, 1883, 10.1084/jem.167.6.1883
Rollins, 1989, The human homolog of the JE gene encodes a monocyte secretory protein, Mol. Cell. Biol., 9, 4687, 10.1128/MCB.9.11.4687
Yoshimura, 1989, Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence, Mol. Immunol., 26, 87, 10.1016/0161-5890(89)90024-2
Cochran, 1983, Molecular cloning of gene sequences regulated by platelet-derived growth factor, Cell, 33, 939, 10.1016/0092-8674(83)90037-5
Van Coillie, 1999, The MCP/eotaxin subfamily of CC chemokines, Cytokine Growth Factor Rev., 10, 61, 10.1016/S1359-6101(99)00005-2
Sozzani, 1995, Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines, J. Immunol., 155, 3292, 10.4049/jimmunol.155.7.3292
Zlotnik, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X
Schecter, 1997, Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells, J. Biol. Chem., 272, 28568, 10.1074/jbc.272.45.28568
Glabinski, 1996, Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain, J. Immunol., 156, 4363, 10.4049/jimmunol.156.11.4363
Ransohoff, 2002, Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence, J. Virol., 76, 2217, 10.1128/jvi.76.5.2217-2224.2002
Schreiber, 2001, Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury, Neuroreport, 12, 601, 10.1097/00001756-200103050-00034
Flugel, 2001, Neuronal MCP-1 expression in response to remote nerve injury, J. Cereb. Blood Flow Metab., 21, 69, 10.1097/00004647-200101000-00009
Rosler, 1998, Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis, J. Neurol. Sci., 157, 82, 10.1016/S0022-510X(98)00061-6
Lahrtz, 1998, Chemokines and chemotaxis of leukocytes in infectious meningitis, J. Neuroimmunol., 85, 33, 10.1016/S0165-5728(97)00267-1
Ivacko, 1997, Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain, J. Cereb. Blood Flow Metab., 17, 759, 10.1097/00004647-199707000-00006
Huang, 2000, Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation, Immunol. Rev., 177, 52, 10.1034/j.1600-065X.2000.17709.x
Asensio, 1999, Chemokines in the CNS: plurifunctional mediators in diverse states, Trends Neurosci., 22, 504, 10.1016/S0166-2236(99)01453-8
Mennicken, 1999, Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning, Trends Pharmacol. Sci., 20, 73, 10.1016/S0165-6147(99)01308-5
Simpson, 1998, Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions, J. Neuroimmunol., 84, 238, 10.1016/S0165-5728(97)00208-7
McManus, 1998, MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study, J. Neuroimmunol., 86, 20, 10.1016/S0165-5728(98)00002-2
Van Der Voorn, 1999, Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions, Am. J. Pathol., 154, 45, 10.1016/S0002-9440(10)65249-2
Sun, 1995, Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus, Virology, 213, 482, 10.1006/viro.1995.0021
Fuentes, 1995, Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1, J. Immunol., 155, 5769, 10.4049/jimmunol.155.12.5769
Fantuzzi, 1999, Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response, Blood, 94, 875, 10.1182/blood.V94.3.875.415k28_875_883
Gunn, 1997, Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation, J. Immunol., 158, 376, 10.4049/jimmunol.158.1.376
Andjelkovic, 1999, Visualization of chemokine binding sites on human brain microvessels, J. Cell Biol., 145, 403, 10.1083/jcb.145.2.403
Dzenko, 2001, The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels, J. Neurosci., 21, 9214, 10.1523/JNEUROSCI.21-23-09214.2001
Huo, 2001, The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium, J. Clin. Invest., 108, 1307, 10.1172/JCI12877
Peterson, 2001, Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions, Ann. Neurol., 50, 389, 10.1002/ana.1123
Sorensen, 1999, Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients, J. Clin. Invest., 103, 807, 10.1172/JCI5150
Sorensen, 2001, Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis, Eur. J. Neurol., 8, 665, 10.1046/j.1468-1331.2001.00327.x
Mahad, 2002, Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 72, 498
Franciotta, 2001, Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies, J. Neuroimmunol., 115, 192, 10.1016/S0165-5728(01)00261-2
Scarpini, 2002, IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease, J. Neurol. Sci., 195, 41, 10.1016/S0022-510X(01)00680-3
Sindern, 2001, Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis, Acta Neurol. Scand., 104, 88, 10.1034/j.1600-0404.2001.104002088.x
Hulkower, 1993, Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis, J. Immunol., 150, 2525, 10.4049/jimmunol.150.6.2525
Glabinski, 1995, Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis, Brain Behav. Immun., 9, 315, 10.1006/brbi.1995.1030
Jiang, 1992, Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes, J. Immunol., 148, 2423, 10.4049/jimmunol.148.8.2423
Solari, 1997, Receptor-mediated endocytosis of CC-chemokines, J. Biol. Chem., 272, 9617, 10.1074/jbc.272.15.9617
Sorensen, 2001, Distinct chemokine receptor and cytokine expression profile in secondary progressive MS, Neurology, 57, 1371, 10.1212/WNL.57.8.1371
Simpson, 2000, Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue, J. Neuroimmunol., 108, 192, 10.1016/S0165-5728(00)00274-5
Tangirala, 1997, Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines, J. Biol. Chem., 272, 8050, 10.1074/jbc.272.12.8050
Zhou, 2001, Regulation of monocyte chemoattractant protein (MCP)-1 transcription by interferon-gamma (IFN-gamma) in human astrocytoma cells: postinduction refractory state of the gene, governed by its upstream elements, FASEB J., 15, 383, 10.1096/fj.00-0373com
Middleton, 1997, Transcytosis and surface presentation of IL-8 by venular endothelial cells, Cell, 91, 385, 10.1016/S0092-8674(00)80422-5
Iarlori, 2002, Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis, J. Neuroimmunol., 123, 170, 10.1016/S0165-5728(01)00487-8
Kivisakk, 1998, No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis, J. Neuroimmunol., 91, 108, 10.1016/S0165-5728(98)00158-1
Kennedy, 1998, Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1, J. Neuroimmunol., 92, 98, 10.1016/S0165-5728(98)00187-8
Ransohoff, 1993, Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis, FASEB J., 7, 592, 10.1096/fasebj.7.6.8472896
Youssef, 1999, Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines, J. Autoimmun., 13, 21, 10.1006/jaut.1999.0306
Rutledge, 1995, High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens, J. Immunol., 155, 4838, 10.4049/jimmunol.155.10.4838
Grewal, 1997, Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1, J. Immunol., 159, 401, 10.4049/jimmunol.159.1.401
Lu, 1998, Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice, J. Exp. Med., 187, 601, 10.1084/jem.187.4.601
Huang, 2001, Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis, J. Exp. Med., 193, 713, 10.1084/jem.193.6.713
Luther, 2001, Chemokines as regulators of T cell differentiation, Nat. Immunol., 2, 102, 10.1038/84205
Karpus, 1998, Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines, J. Exp. Med., 187, 733, 10.1084/jem.187.5.733
Karpus, 1996, The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1, Ann. N Y Acad. Sci., 778, 133, 10.1111/j.1749-6632.1996.tb21122.x
Lukacs, 1997, C-C chemokines differentially alter interleukin-4 production from lymphocytes, Am. J. Pathol., 150, 1861
Heesen, 1996, Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase–polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor, J. Neurosci. Res., 45, 382, 10.1002/(SICI)1097-4547(19960815)45:4<382::AID-JNR7>3.0.CO;2-5
Franci, 1996, Phosphorylation by a G protein-coupled kinase inhibits signaling and promotes internalization of the monocyte chemoattractant protein-1 receptor, Critical role of carboxyl-tail serines/threonines in receptor function, J. Immunol., 157, 5606, 10.4049/jimmunol.157.12.5606
Kivisäkk, 2002, T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking, Clin. Exp. Immunol., 129, 510, 10.1046/j.1365-2249.2002.01947.x
Misu T, Onodera H, Fujihara K, et al. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 2001;114:207–12.
Sorensen, 2002, Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis, Mult. Scler., 8, 104, 10.1191/1352458502ms781oa
Kivisäkk P, Liu Z, Trebst C, et al. Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytes. Methods 2002, in press.
Fife, 2000, CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis, J. Exp. Med., 192, 899, 10.1084/jem.192.6.899
Godiska, 1995, Chemokine expression in murine experimental allergic encephalomyelitis, J. Neuroimmunol., 58, 167, 10.1016/0165-5728(95)00008-P
Berman, 1996, Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat, J. Immunol., 156, 3017, 10.4049/jimmunol.156.8.3017
Nygardas, 2000, Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse, Eur. J. Immunol., 30, 1911, 10.1002/1521-4141(200007)30:7<1911::AID-IMMU1911>3.0.CO;2-E